project id: TCGA-OV; case submitter id: TCGA-24-1930; source center: 22; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.5; spectrophotometer method: UV Spec; age at index: 53; days to birth: -19387; days to death: 2467; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1945; year of death: 2004; age at diagnosis: 19387; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2467.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 1998; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.0; longest dimension: 1.0; preservation method: Unknown; shortest dimension: 0.6; sample id: b9e08539-3921-490e-9f35-013f9704d516; sample submitter id: TCGA-24-1930-01A; portion id: 3d1e9654-d74d-4397-984e-611a5f3d5738; portion submitter id: TCGA-24-1930-01A-01; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;